Currently, the targeting objects of these multifunctional drug delivery nanoplatforms are mainly focused on the inflammatory microenvironment of arthritis (such as infiltrating M1-type macrophages and TNF-) and FLS, aiming to eliminate the adverse effects of these factors [52,53,54]
Inflammation-targeting peptides may complement probiotic therapy by addressing the inflammatory component of gut dysfunction, while KPV peptide has shown specific promise for intestinal inflammation in preclinical research
Key Features: 4 LED wavelengths
[DOI] [PMC free article] [PubMed] [Google Scholar] 46.Shetty R., Basheer F.T., Poojari P.G., Thunga G., Chandran V.P., Acharya L.D
International Diabetes Federation (IDF)